6-K ·Filed May 28, 2026
Notable filing: 6-K
Actionable Insight • Neutral
No market-moving implications. The purchase is a standard RSU settlement mechanism. Monitor upcoming clinical trial readouts or earnings for material catalysts.
Final — all horizons settled through T+60d ⚠ clustered
AAPG ▼ -16.49% at T+60d
NEUTRAL call -16.49% · α vs SPY -17.68% · entry $20.01 → $16.71
T+1d
-4.65%
call -4.65% · α -4.91%
$19.08
settled 5mo ago
T+5d
-14.04%
call -14.04% · α -11.52%
$17.20
settled 5mo ago
T+20d
-11.54%
call -11.54% · α -9.75%
$17.70
settled 4mo ago
T+60d
-16.49%
call -16.49% · α -17.68%
$16.71
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Ascentage Pharma disclosed that its trustee purchased 50,000 existing shares on-market for HK$1,909,800 (HK$38.196/share) under the 2022 RSU scheme, representing ~0.0134% of total shares outstanding. This routine administrative action has no material impact on the company's operations or financials.
Key Facts
- Trustee purchased 50,000 shares on May 28, 2026 at average HK$38.196 per share
- Total consideration HK$1,909,800
- Total shares held by trustee post-purchase: 2,315,000
- Purchase represents approximately 0.0134% of total issued shares
Financial Impact
HK$1.91 million share purchase, immaterial relative to market cap
shares outstanding
Risk Factors
- No material risks identified from this filing
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (14 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-062191 |
| Document: ea029265001-6k_ascentage.htm | 0001213900-26-062191 |
| Document: 0001213900-26-062191-index-headers.html | 0001213900-26-062191 |
| Document: 0001213900-26-062191-index.html | 0001213900-26-062191 |
| Document: 0001213900-26-062191.txt | 0001213900-26-062191 |
29 reports for AAPG
67% Hit rate @ T+1 Went positive at some point 5 of 6 best @ T+20▲ +13.03%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 6-K | $14.92 | awaiting T+1 | — | $15.61 (+4.66%) |
Oct 21, 2026 4d ago | 6-K | $14.92 $15.44 | ▲ +3.49% | ▲ +4.01% | $15.61 (+4.66%) |
Oct 15, 2026 11d ago | 6-K | $14.69 $15.37 | ▲ +4.63% | ▲ +5.74% | $15.61 (+6.30%) |
Sep 17, 2026 5w ago | 6-K | $15.37 $15.06 | ▲ +2.02% | ▲ +1.90% | $15.61 (−1.59%) |
Aug 19, 2026 9w ago | Press Release | $17.32 $17.00 | ▲ +1.85% | ▲ +2.26% | $15.61 (+9.84%) |
Aug 5, 2026 11w ago | 6-K | $16.86 $17.09 | ▲ +1.39% | ▲ +1.55% | $15.61 (−7.36%) |
Aug 3, 2026 12w ago | 6-K | $16.81 $16.69 | ▼ −0.68% | ▼ −2.49% | $15.61 (−7.08%) |
Jul 26, 2026 13w ago | Press Release | $18.89 $18.29 | ▼ −3.20% | ▼ −3.44% | $15.61 (−17.34%) |
Jul 20, 2026 14w ago | 6-K | $18.37 $19.10 | ▲ +3.97% | ▲ +3.14% | $15.61 (−15.00%) |
Jul 13, 2026 14w ago | 6-K | $19.24 $20.18 | ▲ +4.89% | ▲ +4.49% | $15.61 (−18.84%) |
Showing 10 of 29
US Market Status
Market Open — Closes in 4h 3m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers